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Background: Granuloma annulare (GA) is a benign, usually self-limited, inﬂammatory skin disease.
Although there have been several studies that review pathoclinical features about GA, the relevant
epidemiological study in Taiwan was lacking. The purpose of this study is to evaluate the pathoclinical
features and treatment outcome of GA in Taiwan.
Methods: This study was performed by retrospective review of medical records and pathological slides of
the patients diagnosed as GA in a tertiary referral medical center in Taiwan. Fisher exact test was per-
formed to compare remission rate between adults and children, treatment and nontreatment groups.
Result: The study included 44 patients with GA: 23 male and 21 female. The incidence of GA showed a
bimodal age distribution (peaks below 20 years and above 50 years). Localized type is most common,
followed by generalized variant. Perforating GA is the rarest subtype and was exclusively found in
children. The pathology of GA is characterized by necrobiosis (100%), palisading granuloma (81.8%), and
mucin deposition (93.2%); 13.6% and 6.8% of GA patients had history of diabetes mellitus and dyslipi-
demia, respectively.
Conclusion: In contrast to the reported studies, the incidence of GA showed a bimodal age incidence with
slight male preponderance. Our patients had higher prevalence of diabetes mellitus than the general
Taiwanese population but had no increase in incidence of dyslipidemia. Whether patients received
treatment or not does not affect the disease outcome. Overall, children have better prognosis than adults.
Copyright © 2015, Taiwanese Dermatological Association.
Published by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Granuloma annulare (GA) is a benign, and usually self-limited, in-
ﬂammatory skin disease. The disease incidence is estimated1 to be
between 0.1% and 0.4%. The clinical manifestations vary, fromy have no ﬁnancial or non-
atter or materials discussed
ogy, Kaohsiung Chang Gung
ge of Medicine, Ta-Pei Road
al Association. Published by Elsevilocalized, erythematous to ﬂesh-colored papules with annular
arrangement to the more generalized form. GA can develop in any
skin areas, but it tends to occur on the lateral or dorsal surfaces of
the hands and feet. GA is usually self-limited. The pathogenesis of
GA remains unclear although abnormal repair in vascular injury or
aberrant responses in delayed-type hypersensitivity may be
involved. The diagnosis is made clinically or by skin biopsy with the
typical histological ﬁndings of eosinophilic necrobiosis and pali-
sading lymphohistiocytic inﬁltrates.
GA was reported to commonly affect children and young adults
with a female preponderance based on hospital based studies
performed in USA, Singapore, Switzerland, and UK.2e4 However, a
recent study in Korea reported a bimodal distribution of onset ageer Taiwan LLC. This is an open access article under the CC BY-NC-ND license (http://
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GA.5 The mixed clinical and epidemiological pattern of GA might
depend on the variations in clinical categorizations, races, and
associated triggering factors. In Taiwan, several individual cases of
GA have been reported; however, a comprehensive study to
delineate the clinical categorizations, treatment outcome, associ-
ated disease, and histopathological features of GA is lacking.
Therefore, we herein aimed to evaluate the clinical ﬁndings, his-
topathological features, associated diseases, and treatment out-
comes in Taiwanese patients of GA.Method
This study was performed by a retrospective review of medical
records and pathological slides of the patients diagnosed as GA in
Kaohsiung Chang Gung Memorial Hospital, a tertiary referral
medical center from January 2002 to January 2013. In total, 44
patients were identiﬁed. Information including sex, age of onset,
location, number and type of lesions, onset duration, clinical
morphology, associated diseases, treatment and outcome were
collected. Children were deﬁned as those younger than 18 years.
Skin specimens were ﬁxed in formalin, later embedded in parafﬁn,
and sectioned with 4-mm thickness. Sections were stained with
hematoxylin and eosin and Alcian blue (pH ¼ 2.5). Histopatholog-
ical features including distribution patterns of inﬂammatory cells,
mucin deposition, and inﬁltrative cell type were analyzed. The
microscope slides were reviewed independently by one board-
certiﬁed pathologist and one board-certiﬁed dermatologist. The
diagnoses were made according to the constellation of clinical and
pathological ﬁndings.
Based on clinical manifestations, the disease was classiﬁed into
localized, generalized, subcutaneous, and perforating types. Soli-
tary or a few lesions on a single anatomical site were deﬁned as
localized form. Generalized GAwas deﬁned as affecting at least the
trunk and either upper, lower, or both limbs, based on the criteria
initially stated by Dabski and Winkeiann.6 Subcutaneous GA was
characterized by granuloma predominantly affecting subcutaneousFigure 1 Clinical variants of granuloma annulare: (A) annular lesion; (B)tissue while perforating GAwas featured by superﬁcial umbilicated
papules and transepidermal elimination of necrobiotic collagen.
Representative clinical features for subtypes of GA are shown in
Figure 1.
Treatment options with either systemic or topical medication
were recorded. The treatment response was assessed by the
dermatologist and by the patient. Follow-up was carried out by
either medical charts or telephone interviews. Treatment response
was classiﬁed as poor (no response), partial, or good (complete or
nearly complete resolution).
Fisher exact test was performed to compare remission rate be-
tween adults and children, with or without treatment.
Results
Demographic data and clinical features of GA
In this study, 44 patients with GAwere identiﬁed, of whom 23were
male and 21 female. The age of onset widely distributed, ranging
from 2 years to 75 years (average age¼ 36.55 ± 24.86 years, median
age¼ 40 years). Sixteen patients were children (36.4%) and 28 were
adults (63.6%). A bimodal age distribution (peaks below 20 years
and above 50 years) was noted (Figure 2). Nearly half of the patients
(43.2%) had the disease in their 5th decade. Among the four clinical
variants, the localized type is the most common, followed by the
generalized variant. Subcutaneous GA occurs most often in children
and young adults. Perforating GA is the rarest subtype and exclu-
sively occurred in children. Themajority of the lesions exhibited the
clinical pattern of annular arrangement and papular morphology
(Table 1). The mean disease duration is 9.5 months.
Association of metabolic diseases and GA
Among the 28 adult GA patients, six had diabetes mellitus (DM:
exclusively noninsulin dependent DM), four had hypertension,
three had dyslipidemia (1 had hypertriglyceridemia and 2 had
hypercholesterolemia), one had history of ischemic stroke, and onepapular lesion; (C) subcutaneous lesion; and (D) perforated lesion.
Figure 2 Clinical variants of granuloma annulare (GA) in different age groups. Local-
ized GA showed a bimodal distribution of affected ages. Generalized GA predominately
affects adults older than 50 years, although the pediatric population is also affected.
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metabolic syndrome. DM was found in ﬁve of the 13 patients with
generalized GA (38.5%) and in one of the 14 patients with localized
GA (7.1%; Figure 3). It appears that patients with generalized GA are
more likely to develop DM than those with localized disease,
although the difference did not reach statistical signiﬁcance
(p ¼ 0.0691). In contrast to adult patients, none of the pediatric
patients had concurrent chronic disease.
Histopathological ﬁndings
In all cases, the pathological ﬁndings involved histiocytic inﬁltra-
tion with necrobiosis. The histiocytes were arranged with a pali-
sading pattern in 28 patients (63.6%), with an interstitial
distribution dissecting collagen bundles in eight patients (18.2%)
and the other eight patients (18.2%) had mixed distribution pattern
of palisading and interstitial inﬁltration. Of the 44 specimens, 41
stained positively for mucin (93.2%). The inﬂammatory inﬁltrates
were predominantly lymphocytes in all cases although in eight
patients concomitant eosinophil inﬁltrates were also present
(18.2%). Multinucleated giant cells were observed in seven cases
(15.9%).
Treatment and recurrence rate
We were able to follow up the treatment outcomes in 35 patients
(79.5% follow-up rate) including 22 adults and 13 children. The
average follow-up period was 66.9 months. Among the 17 adult GA
patients with treatment, 12 received topical steroid or intralesional
steroid, and three of them achieved complete remission. Overall
remission rate (complete plus partial) in the treated group was
76.5% (13/17). Five adult patients received oral dapsone. Of those
patients, two patients had partial response while three othersTable 1 Demographic data of the 44 patients.
Variables Results, n (%)
Age (y), range (median) 2e75 (40)
Sex
Male 23 (52.3)
Female 21 (47.7)
Clinical variant
Localized 22 (50.0)
Generalized 16 (36.4)
Perforating 2 (4.5)
Subcutaneous 4 (9.1)
Morphology
Papular predominance 17 (38.6)
Annular predominance 20 (45.5)
Perforating 3 (6.8)
Subcutaneous 4 (9.1)reported good response. In adult patients without treatment
(n ¼ 5), four (80%) reported disease remission (good response).
In eight pediatric patients with treatment (n ¼ 8), all showed
good to partial response to treatments (100% remission rate;
Table 2). Among ﬁve pediatric patients without treatment, only one
showed no remission (80% remission rate). Pediatric patients have
statistically higher percentage of remissions [complete remission
rate 45.5% (10/22) vs 84.6% (11/13) in adult and pediatric patients,
respectively; Table 3].
In terms of treatment choices in different GA subtypes among
adult and pediatric patients, patients with generalized GA all
received treatments (n ¼ 13 and 3 in adult and pediatric patients,
respectively). In subcutaneous variants, all patients did not receive
any treatments (n ¼ 1 and 3 in adult and pediatric patients,
respectively). For the localized variants, around half of the adult
and the children received treatments (4/8 and 3/5 in adult and
pediatric patients respectively). Two pediatric patients with
perforating GA received dapsone.
Recurrences, deﬁned as new lesions attack after clinically
complete clearance, were noted in three adult and two pediatric
patients. The disease-free interval varied from 3months to 10 years.
Discussion
GA is a chronic, benign inﬂammatory skin disease that usually
presents as annular plaques located on the extremities of young
people. Age onset of GA was reported mostly in the ﬁrst 3 decades
in the previous literature.2e4,7 Majority of previous studies1,2
demonstrate female preponderance. However, in our study, it has
a bimodal age distribution (one peak below 20 years and the other
above 50 years) with slight male preponderance (male:
female ¼ 1.09: 1). Most patients were older than 50 years. In this
study, consistent with previous literature, localized GA is the most
frequent clinical variant in either children or adults. However, in
this study, the prevalence of generalized GA in our patients (36.4%)
is higher than that reported in other previous studies (range,
5e25.8%). Dabski and Winkeiann6 divided the clinical appearance
of generalized GA into two forms. In the present study, the pre-
dominantly annular form accounted for 45.5%, whereas the pre-
dominant papular form accounted for 38.6%. Subcutaneous GA
occurs most often in children and young adults. Perforating GAwas
the rarest subtype and exclusively seen in children.
The pathogenesis of GA has not been fully elucidated. Most
patients cannot identify any precipitating factors. Reported
precipitating factors in the literature were trauma,1 sunburn,8 in-
sect bite,9 Bacillus CalmetteeGuerin vaccination,10,11 drugs,12 upper
respiratory infection,5 reaction to intravenous contrast medium,
phlebitis, sepsis after surgery, and stress.Figure 3 Association of medical diseases with localized and generalized granuloma
annulare (GA). Generalized GA was associated with higher prevalence of diabetes
mellitus (DM) and had the trends with other chronic disease such as hypertension,
dyslipidemia, and metabolic syndrome.
Table 2 Treatment response in patients with GA.
Treatment modality of adult patients Poor response Partial response Good response
With treatment (n ¼ 17) 4 7 6
No treatment (n ¼ 5) 1 0 4
All (n ¼ 22) 5 7 10
Treatment modality of pediatric patients Poor response Partial response Good response
With treatment (n ¼ 8) 0 1 7
No treatment (n ¼ 5) 1 0 4
All (n ¼ 13) 1 1 11
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ship between GA and other systemic diseases, with DM most
noteworthy. The association of GA with DM remains controversial.
Studer et al3 noted that 10 of 84 adult patients (12%) with GA
(localized or generalized) had DM, as opposed to the 5% prevalence
of DM among the regional population. However, other studies13,14
that looked for carbohydrate intolerance by performing glucose
tolerance testing or assessing the hemoglobin A1c values failed to
ﬁnd an increased prevalence of altered carbohydratemetabolism in
the patients with GA. Our study showed that the prevalence of DM
in GA patient is 13.6% (5 generalized GA and 1 localized GA), which
is higher than general adult population in Taiwan (6.38%).15 In our
study, patients with generalized GA were more likely to develop
DM than those with localized disease, although the difference was
not statistically signiﬁcance (p ¼ 0.0691). Although the association
between GA and DM is not settled, we recommended DM workup
for the GA patients, especially for those who presented generalized
typed GA and age over 50 years.
Recently, several authors suggest a possible relationship be-
tween GA and dyslipidemia. In the study by Wu et al,16 dyslipide-
mia was more common in generalized than localized disease, and
the annular lesion morphology was associated with hypercholes-
terolemia. Their cases with hyperlipidemia improved in their GA
after effective lipid-lowering treatment. However, the prevalence of
dyslipidemia in our patients was 6.8%, which seems not signiﬁ-
cantly higher than general population in Taiwan (11.2%).17 Dyslipi-
demia work up may be recommended in generalized GA, but
further study for association between GA and dyslipidemia is
needed.
GA is characterized by necrobiosis, granulomatous inﬂamma-
tion and mucin deposition. Necrobiosis was the most common
pathological presentation in our study (100% in all biopsy speci-
mens). Mucin was noted in 93.2% of all biopsy specimens. The
presence of mucin helps differentiate GA from other dermatoses
with palisading granuloma. The inﬂammatory cellular component
consists of predominantly histiocytes (some of which are epitheloid
or multinucleated), lymphocytes (the majority of which are T
helper cells) and occasionally eosinophils. All patient with subcu-
taneous GA (n¼ 4) in our study had eosinophils inﬁltration and this
is compatible with previous observation18 in which eosinophils are
more commonly seen in subcutaneous GA.Table 3 Follow-up: comparison of treatment response and recurrence rate among
adult and pediatric patients with granuloma annulare.
Variables Adult (%) Children (%) p
Cases of complete remission 10/22 (45.5) 11/13 (84.6) 0.033*
Generalized type 5/13 (38.5) 2/3 (66.6) 0.55
Localized type 5/8 (62.5) 5/5 (100) 0.23
Other type 0/1 (0) 4/5 (80) 0.33
Recurrence cases 3/22 (13.6) 2/13 (15.4) 0.891
*p <0.05.Because localized GA is self-limited and asymptomatic, treat-
ment usually is not necessary. Systemic therapy may be required
for disseminated GA, and many different treatments have been
proposed. Dapsone,19 isotretinoin,20e22 antimalarial agents,23
cyclosporine,24 psoralen combined with ultraviolet A,25,26
topical imiquimol,27 or potassium iodide28 have shown positive
outcome for generalized GA treatment. There is no large-scale
double blind randomized controlled trial on treatment. Together
with the fact that spontaneous resolution may occur, it is difﬁcult
to interpret the reported efﬁcacy of various treatments. According
to our study, there are differential responses to treatment be-
tween adults and children. Adult patients without treatment had
better disease outcome (good response rate) than those with
treatment (good response rate, treatment: no treatment, 35%:
80%). The possible reason for this is that the patients receiving
treatment clinically had more extensive disease and longer dis-
ease duration, which may imply that it is refractory to treatment.
By contrast, 87.5% of children patients can achieve complete
remission after treatment. In addition, 80% of pediatiric patients
without treatment also reported complete remission. Overall
children have better prognosis than adults, especially in localized
type GA (Table 3). Watchful waiting or symptomatic treatment
may be sufﬁcient for children.
It was not possible to determine the remission period due to
recall error. Therefore, whether the treatment hastens the disease
remission or not cannot be evaluated. Future study may be needed
to record the period from the onset of the disease to complete
remission. Detailed records may help in reaching better cost-
effectiveness and decision-making in treating GA.Conclusions
GA is a benign, usually self-limited, inﬂammatory skin disease. In
contrast to reported studies, the age distribution of GA in Taiwan
showed a bimodal-age incidence with slightly male preponder-
ance. Patients with GA, with the generalized form in particular, are
more likely to develop DM.Whether patients received treatment or
not does not signiﬁcantly affect the disease outcome. Overall, the
children had better prognosis than adults in our study.References
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